Q4 2022 13F Holders as of 31 Dec 2022
-
Type / Class
-
Equity / Common Stock, $0.001 par value per share
-
Shares outstanding
-
54,053,214
-
Total 13F shares
-
50,610,019
-
Share change
-
-574,373
-
Total reported value
-
$368,439,290
-
Put/Call ratio
-
7.4%
-
Price per share
-
$7.28
-
Number of holders
-
108
-
Value change
-
-$5,888,182
-
Number of buys
-
68
-
Number of sells
-
38
Institutional Holders of Fulcrum Therapeutics, Inc. - Common Stock, $0.001 par value per share (FULC) as of Q4 2022
As of 31 Dec 2022,
Fulcrum Therapeutics, Inc. - Common Stock, $0.001 par value per share (FULC) was held by
108 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
50,610,019 shares.
The largest 10 holders included
RA CAPITAL MANAGEMENT, L.P., FMR LLC, RTW INVESTMENTS, LP, SUVRETTA CAPITAL MANAGEMENT, LLC, BlackRock Inc., TRV GP IV, LLC, VANGUARD GROUP INC, Logos Global Management LP, TRV GP III, LLC, and COWEN AND COMPANY, LLC.
This page lists
109
institutional shareholders reporting positions in this security
for the Q4 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.